189 related articles for article (PubMed ID: 25320223)
1. Hospitalized infections in giant cell arteritis: a population-based retrospective cohort study.
Udayakumar PD; Chandran AK; Crowson CS; Warrington KJ; Matteson EL
J Rheumatol; 2014 Dec; 41(12):2447-51. PubMed ID: 25320223
[TBL] [Abstract][Full Text] [Related]
2. Incidence of infections in patients with giant cell arteritis: a cohort study.
Durand M; Thomas SL
Arthritis Care Res (Hoboken); 2012 Apr; 64(4):581-8. PubMed ID: 22184094
[TBL] [Abstract][Full Text] [Related]
3. Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
Semin Arthritis Rheum; 2017 Apr; 46(5):650-656. PubMed ID: 27839741
[TBL] [Abstract][Full Text] [Related]
4. Hospitalization rates and utilization among patients with giant cell arteritis: A population-based study from 1987 to 2012.
Michet CJ; Achenbach SJ; Crowson CS; Matteson EL
Semin Arthritis Rheum; 2015 Aug; 45(1):70-4. PubMed ID: 25824865
[TBL] [Abstract][Full Text] [Related]
5. Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study.
Singh JA; Cleveland JD
Clin Rheumatol; 2020 Nov; 39(11):3427-3438. PubMed ID: 32399772
[TBL] [Abstract][Full Text] [Related]
6. Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.
Mohammad AJ; Englund M; Turesson C; Tomasson G; Merkel PA
J Rheumatol; 2017 Jan; 44(1):84-90. PubMed ID: 27803140
[TBL] [Abstract][Full Text] [Related]
7. Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study.
Schäfer VS; Kermani TA; Crowson CS; Hunder GG; Gabriel SE; Ytterberg SR; Matteson EL; Warrington KJ
Rheumatology (Oxford); 2010 Nov; 49(11):2104-8. PubMed ID: 20627970
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk and acute coronary syndrome in giant cell arteritis: a population-based retrospective cohort study.
Udayakumar PD; Chandran AK; Crowson CS; Warrington KJ; Matteson EL
Arthritis Care Res (Hoboken); 2015 Mar; 67(3):396-402. PubMed ID: 25074472
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Severe Infections and Infection-Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double-Cohort Study.
Schmidt J; Smail A; Roche B; Gay P; Salle V; Pellet H; Duhaut P
Arthritis Rheumatol; 2016 Jun; 68(6):1477-82. PubMed ID: 26815885
[TBL] [Abstract][Full Text] [Related]
10. Burden, Causes, and Outcomes of Hospitalization in Patients With Giant Cell Arteritis: A US National Cohort Study.
Goulabchand R; Qian AS; Nguyen NH; Singh AG; Roubille C; Parreau S; Singh N; Singh S
Arthritis Care Res (Hoboken); 2023 Aug; 75(8):1830-1837. PubMed ID: 36576029
[TBL] [Abstract][Full Text] [Related]
11. [Hospitalization for infection in patients treated for giant cell arteritis: A single-centre retrospective study].
Lavrard-Meyer P; Gomes De Pinho Q; Daumas A; Benyamine A; Ebbo M; Schleinitz N; Harlé JR; Jarrot PA; Kaplanski G; Berbis J; Granel B
Rev Med Interne; 2023 May; 44(5):212-217. PubMed ID: 37029032
[TBL] [Abstract][Full Text] [Related]
12. Infections Are Associated With Increased Risk of Giant Cell Arteritis: A Population-based Case-control Study from Southern Sweden.
Stamatis P; Turkiewicz A; Englund M; Jönsson G; Nilsson JÅ; Turesson C; Mohammad AJ
J Rheumatol; 2021 Feb; 48(2):251-257. PubMed ID: 32414956
[TBL] [Abstract][Full Text] [Related]
13. Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
Brekke LK; Diamantopoulos AP; Fevang BT; Aβmus J; Esperø E; Gjesdal CG
Arthritis Res Ther; 2017 Dec; 19(1):278. PubMed ID: 29246164
[TBL] [Abstract][Full Text] [Related]
14. All-cause and cause-specific mortality in patients with giant cell arteritis: a nationwide, population-based cohort study.
Therkildsen P; Nielsen BD; de Thurah A; Hansen IT; Nørgaard M; Hauge EM
Rheumatology (Oxford); 2022 Mar; 61(3):1195-1203. PubMed ID: 34164660
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia.
Kramarič J; Ješe R; Tomšič M; Rotar Ž; Hočevar A
Clin Rheumatol; 2022 Aug; 41(8):2449-2456. PubMed ID: 35366735
[TBL] [Abstract][Full Text] [Related]
16. Infections and the risk of incident giant cell arteritis: a population-based, case-control study.
Rhee RL; Grayson PC; Merkel PA; Tomasson G
Ann Rheum Dis; 2017 Jun; 76(6):1031-1035. PubMed ID: 27895041
[TBL] [Abstract][Full Text] [Related]
17. Inpatient complications in patients with giant cell arteritis: decreased mortality and increased risk of thromboembolism, delirium and adrenal insufficiency.
Unizony S; Menendez ME; Rastalsky N; Stone JH
Rheumatology (Oxford); 2015 Aug; 54(8):1360-8. PubMed ID: 25667435
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Cardiovascular Hospitalization in Giant Cell Arteritis: Effect of Statin Exposure. A French Population-based Study.
Pugnet G; Sailler L; Fournier JP; Bourrel R; Montastruc JL; Lapeyre-Mestre M
J Rheumatol; 2016 Dec; 43(12):2162-2170. PubMed ID: 27585686
[TBL] [Abstract][Full Text] [Related]
19. The Detection of Rheumatic Disease through Hospital Diagnoses with Examples of Rheumatoid Arthritis and Giant Cell Arteritis: What Are We Missing?
John Michet C; Crowson CS; Achenbach SJ; Matteson EL
J Rheumatol; 2015 Nov; 42(11):2071-4. PubMed ID: 26233503
[TBL] [Abstract][Full Text] [Related]
20. Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden.
Zöller B; Li X; Sundquist J; Sundquist K
Scand J Rheumatol; 2013; 42(6):487-97. PubMed ID: 23815287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
